Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction

咽喉反流 医学 回流 病史 家族史 疾病 内科学 儿科
作者
Marie Mailly,Robin Baudouin,Camille Thibault,Stéphane Hans,Jérôme R. Lechien
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:151 (4): 396-396 被引量:7
标识
DOI:10.1001/jamaoto.2024.5046
摘要

Importance Retrograde cricopharyngeus dysfunction (R-CPD) is an emerging disorder associated with disabling symptoms. The origin of R-CPD remains unknown. Objective To investigate the development of symptoms, diagnosis approach, and therapeutic outcomes of R-CPD in patients treated with in-office botulinum toxin injection (BTI) into the cricopharyngeus. Design, Setting, and Participants This was a case series including patients with R-CPD who were consecutively and prospectively recruited from April 2022 to May 2024 in an academic hospital. Semistructured interviews were conducted to collect and analyze data on each patient’s clinical history, potential causes or factors associated with R-CPD development, diagnostic approaches, and symptom presentation. Intervention Clinic-based (in-office) BTI into the cricopharyngeus. Outcomes and Measures Associations with laryngopharyngeal reflux disease, patients’ Reflux Symptom Score-12 (RSS-12), and BTI effectiveness, revisions, and complications were evaluated. Results The case series comprised 106 patients with R-CPD treated with BTI (52 females [49.1%] and 54 males [51.9%]). Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years. Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents’ testimonies. A family history was reported in 18 of 62 cases (29.0%). In 105 cases (99.1%), patients made the diagnosis themselves despite medical consultations (n = 162), empirical treatments (n = 113), and additional examinations (n = 92). The cumulative success rate of BTI was 90.6% (96 of 106 patients). In 26 cases (24.5%), additional injections were administered to address the symptoms. Family history of R-CPD was a negative predictor of single-BTI success. Dysphagia was the primary adverse effect occurring after 89 of 126 BTIs (70.6%) and lasted a mean (SD) of 16.3 (12.0) days. In 10 cases, operating-room BTI was administered after primary in-office BTI. Conclusions and Relevance R-CPD is an emerging and poorly known disorder associated with high rates of ineffective consultations, additional examinations, and self-diagnosis by patients. In-office BTI was associated with a high rate of partial or total symptom relief and long-term effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刘华珍完成签到,获得积分10
1秒前
1秒前
段辉完成签到,获得积分10
2秒前
Lucas的应助被toppkj采纳,获得10
3秒前
lizhehao完成签到,获得积分10
3秒前
香蕉觅云的应助被紫熊采纳,获得10
3秒前
TY完成签到 ,获得积分10
4秒前
szjqq完成签到,获得积分10
4秒前
rzxhygr完成签到,获得积分10
5秒前
乔凌云完成签到 ,获得积分10
6秒前
天天快乐的应助被学术雷锋采纳,获得10
7秒前
陨落的繁星完成签到,获得积分10
7秒前
务实青筠完成签到 ,获得积分10
8秒前
nusiew完成签到,获得积分10
8秒前
勤奋的毛豆完成签到,获得积分10
8秒前
爱沉淀的太阳花完成签到,获得积分10
9秒前
热心的梦柏完成签到 ,获得积分10
10秒前
织梦完成签到 ,获得积分10
10秒前
tszjw168发布了新的文献求助10
11秒前
szj完成签到,获得积分10
11秒前
星星完成签到 ,获得积分10
12秒前
xixi2517完成签到,获得积分10
12秒前
端庄的猕猴桃完成签到 ,获得积分10
13秒前
bigger.b完成签到,获得积分0
15秒前
rongrong12完成签到,获得积分10
15秒前
seawolf168完成签到,获得积分10
16秒前
海底烤鱼饭完成签到,获得积分10
18秒前
小时完成签到 ,获得积分10
19秒前
苹果思烟完成签到,获得积分10
20秒前
文静的紫萱完成签到,获得积分10
21秒前
苗苗完成签到,获得积分10
22秒前
牙牙完成签到,获得积分10
25秒前
北海完成签到,获得积分10
26秒前
笑点低的凉面完成签到,获得积分10
30秒前
zzzzlololo完成签到,获得积分10
32秒前
系统昵称完成签到,获得积分10
32秒前
天马完成签到,获得积分10
33秒前
调皮的以柳完成签到,获得积分10
33秒前
沐秋完成签到,获得积分10
34秒前
雪球汤姆完成签到,获得积分10
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159131
求助须知:如何正确求助?哪些是违规求助? 9554607
关于积分的说明 21719706
捐赠科研通 7748769
什么是DOI,文献DOI怎么找? 3427149
关于科研通互助平台的介绍 2552079
邀请新用户注册赠送积分活动 2471428